Mint Explainer: The rationale behind bringing 44 drugs under price control
# What measures do drug manufacturers & retailers have to take now? A drug manufacturer will have to issue a price list to NPPA through Integrated Pharmaceutical Database Management System (IPDMS) and submit a copy to State Drug Controller and dealers. Every retailer and dealer shall display the price list as furnished by the manufacturer at his business premises in a manner easily accessible to any person wishing to consult the same.
Manufacturers not complying with regulations are liable to deposit overcharged amount as per the provisions of the DPCO, 2013 and Essential Commodities Act 1955. So far, retail prices of around 2,450 new drugs have been fixed.
In July, ceiling price of 915 scheduled formulations were notified. During the covid-19 pandemic, NPPA regulated the price of oxygen concentrators, pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer under “Trade Margin Rationalization".
Read more on livemint.com
